Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,723 | 10,778 | 12,153 | 17,734 | 17,456 |
| Receivables | 7,862 | 8,221 | 9,048 | 7,803 | 7,525 |
| Inventories | 8,139 | 7,106 | 6,823 | 7,483 | 9,058 |
| Other current assets | 1,370 | 1,389 | 2,011 | 1,048 | 0 |
| TOTAL | $29,094 | $27,494 | $30,035 | $34,068 | $35,400 |
| Non-Current Assets | |||||
| PPE Net | 1,338 | 1,267 | 1,048 | 972 | 997 |
| Intangibles | 105,626 | 109,675 | 116,047 | 117,177 | 122,122 |
| Other Non-Current Assets | 1,471 | 1,792 | 1,942 | 1,730 | 1,385 |
| TOTAL | $108,435 | $112,734 | $119,037 | $119,879 | $124,504 |
| Total Assets | $137,529 | $140,228 | $149,072 | $153,947 | $159,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,325 | 4,257 | 5,751 | 5,272 | 4,828 |
| Accounts payable and accrued liabilities | 10,438 | 10,587 | 8,339 | 8,682 | 8,709 |
| Other current liabilities | N/A | N/A | 878 | 512 | 33 |
| TOTAL | $26,121 | $23,456 | $27,589 | $23,840 | $22,545 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44,453 | 48,834 | 48,969 | 57,634 | 60,740 |
| Other Non-Current Liabilities | 1,673 | 1,773 | 1,373 | 1,130 | 778 |
| TOTAL | $49,738 | $55,033 | $54,924 | $63,309 | $66,018 |
| Total Liabilities | $75,859 | $78,489 | $82,513 | $87,149 | $88,563 |
| Shareholders' Equity | |||||
| Common Shares | 256,338 | 256,351 | 258,063 | 260,136 | 260,595 |
| Retained earnings | -204,152 | -202,823 | -199,834 | -198,333 | -194,180 |
| Other shareholders' equity | -6,680 | -7,698 | -6,458 | -9,898 | -10,210 |
| TOTAL | $61,670 | $61,739 | $66,559 | $66,798 | $71,341 |
| Total Liabilities And Equity | $137,529 | $140,228 | $149,072 | $153,947 | $159,904 |